1,640 results on '"Hoelzer, Dieter"'
Search Results
2. Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia
3. International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia.
4. Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion
5. Management of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel
6. Diagnosis, Prognostic Factors and Assessment of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel
7. Diagnosis and Treatment of Adult Acute Lymphoblastic Leukemia
8. “Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions”—Treatment of ALL
9. Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation
10. Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
11. Clinician Concepts of Cure in Adult Relapsed and Refractory Philadelphia-Negative B Cell Precursor Acute Lymphoblastic Leukemia: A Delphi Study
12. Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial
13. Current status and future clinical directions in the prevention and treatment of relapse following hematopoietic transplantation for acute myeloid and lymphoblastic leukemia
14. Publisher Correction: Rolf Neth (October 6, 1926–March 17, 2020)
15. Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a review
16. S114: OUTCOME OF OLDER PATIENTS (>55 YRS) WITH NEWLY DIAGNOSED PH/BCR:ABL POSITIVE ALL PROSPECTIVELY TREATED ACCORDING TO PEDIATRIC-BASED, AGE-ADAPTED GMALL PROTOCOLS
17. Lymphoblastic lymphoma
18. Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemia
19. Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL
20. Rolf Neth (October 6, 1926 to March 17, 2020)
21. Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures
22. General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia
23. Burkitt Lymphoma
24. Diagnosis and Treatment of Adult Acute Lymphoblastic Leukemia
25. Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial
26. The Hematopoietic Growth Factors in Acute Leukemia: A European Perspective
27. Outcome of 841 Older Patients (>55 yrs) with Newly Diagnosed Ph/BCR-ABL Negative ALL Prospectively Treated According to Pediatric-Based, Age-Adapted GMALL Protocols
28. Akute Iymphatische Leukämie bei Erwachsenen und Kindern
29. Treatment of Lymphoblastic Lymphoma in Adults
30. Treatment of Adult ALL According to Protocols of the German Multicenter Study Group for Adult ALL (GMALL)
31. Diagnosis and Treatment of Adult Acute Lymphoblastic Leukemia
32. Entstehung, Entwicklung und Erfolge des Kompetenznetzes Akute und Chronische Leukämien (KNL)
33. Outcome of 841 Older Patients (>55 yrs) with Newly Diagnosed Ph/BCR-ABL Negative ALL Prospectively Treated According to Pediatric-Based, Age-Adapted GMALL Protocols
34. MicroRNA profiling reveals aberrant microRNA expression in adult ETP-ALL and functional studies implicate a role for miR-222 in acute leukemia
35. Treatment of Adult Acute Lymphoblastic Leukemia : Perspective 2
36. Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation
37. Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies
38. Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell–engaging CD19/CD3-bispecific BiTE antibody blinatumomab
39. Chemoimmunotherapy in acute lymphoblastic leukemia
40. Acute leukaemias
41. Immunological Response to IL-2 and α-IFN-Treatment After Autologous BMT in Patients with BCR-ABL-positive ALL
42. Interleukin-2 Bolus Infusion as Consolidation Therapy in 2nd Remission of Acute Myelocytic Leukemia
43. Expression of CD7 and CD15 on Leukemic Blasts Are Prognostic Parameters in Patients with Acute Myelocytic Leukemia — Irrelevance of CD34
44. Lymphoblastic lymphoma
45. Epigenetic regulation of PAX5 expression in acute T-cell lymphoblastic leukemia
46. The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia
47. Long-term results of a prospective randomized trial evaluating G-CSF priming in intensive induction chemotherapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemia
48. Establishment of a Genetic System to Coordinate Feeder Cell Growth in Cocultures with Primary Cells
49. High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia
50. Optimal Use of Bendamustine in Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphomas, and Multiple Myeloma: Treatment Recommendations From an International Consensus Panel
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.